日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
24/10/2024 | 上海张科领弋升帆创业投资中心(有限合夥) | 1201(L) | -3,165,000(L) | HKD5.900(L) | 20,909,600(L) | 5.99 |
23/10/2024 | 于晓勇 | 1201(L) | -4,061,800(L) | HKD5.750(L) | 27,242,505(L) | 7.81 |
21/10/2024 | 上海张科领弋升帆创业投资中心(有限合夥) | 1201(L) | -1,675,400(L) | HKD5.690(L) | 24,074,600(L) | 6.90 |
04/10/2024 | 施毅 | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
04/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
02/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
02/10/2024 | 施毅 | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
30/09/2024 | 于晓勇 | 1706(L) | 31,304,305(L) | 8.97 | ||
25/09/2024 | 施毅 | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
25/09/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
05/09/2024 | Halo Biomedical LP | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | 田文志 | 1201(L) | -2,655,855(L) | 115,884,090(L) | 33.20 | |
04/09/2024 | 田文志 | 1711(L) | -50,269,972(L) | 0(L) | 0.00 | |
04/09/2024 | 于晓勇 | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
04/09/2024 | 施毅 | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | Jiaxing Changxian Enterprise Management L.P. (Limited Partnership) (嘉兴昶咸企业管理合夥企业(有限合夥)) | 1711(L) | -7,758,630(L) | 0(L) | 0.00 | |
04/09/2024 | Ho Yao | 1701(L) | +4,002,918(L) | 16,011,675(L) | 4.59 | |
04/09/2024 | LAV Corporate V GP, Ltd. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | 田文志 | 1711(L) | +50,269,972(L) | 118,539,945(L) | 33.96 | |
04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
04/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | Halo Biomedical LP | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | LAV GP V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | Jiaxing Changyu Enterprise Management L.P. (Limited Partnership) (嘉兴昶宇企业管理合夥企业(有限合夥)) | 1711(L) | -7,419,847(L) | 0(L) | 0.00 | |
04/09/2024 | LAV Biosciences Fund V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
04/09/2024 | 上海张科领弋升帆创业投资中心(有限合夥) | 1113(L) | +25,750,000(L) | 25,750,000(L) | 7.38 | |
04/09/2024 | LAV ImmOn Hong Kong Limited | 1213(L) | 12,542,805(L) | 12,542,805(L) | 3.59 | |
04/09/2024 | LAV Asset Management (Hong Kong) Limited | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | 于晓勇 | 1113(L) | +25,750,000(L) | 31,304,305(L) | 8.97 | |
04/09/2024 | LAV ImmuneOnco Hong Kong Limited | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | 上海张科领弋升帆创业投资中心(有限合夥) | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
03/09/2024 | 陈飞 | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
03/09/2024 | Greater Bay Area Homeland Development Fund (GP) Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | Greater Bay Area Homeland Investments Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
1 2 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 01/11/2024 09:24 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |